Tag: GWAS

  • 中医九种体质的多中心GWAS重复验证:从初步关联到可复现的表型指纹

    Evidence level: A

    体质分型已有多条遗传学证据线,但要让”九种体质=可遗传表型指纹”成为被现代遗传学接受的结论,必须完成多中心大样本GWAS+跨群体meta这条最后验证链路。

    正文

    问题:体质量表能测出你是”痰湿质”还是”平和质”,但这套分型在基因组层面站得住吗?已有答案是”有初步证据”,但距离”严格验证”还差最后一公里——多中心重复。

    一、体质分型的遗传学证据已经存在

    体质差异的遗传基础并非空谈。2009年,韩国庆熙大学对四象体质医学做了首次全基因组关联研究(GWAS),在353,202个SNP位点上发现四象类型两两比较有15,944个SNP显著差异,其中5个SNP在所有比较中共同显著(PMID 19954339)。同一时期,北京中医药大学王琦团队对痰湿质做基因表达谱分析,发现4个上调基因(COPS8、GNPDA1、CD52、ARPC3)与6个下调基因(GSPT2、CACNB2等),功能指向高脂血症与糖尿病易感性(PMID 23548117)——”痰湿质容易得代谢病”在分子层面有了第一个锚点。

    候选基因研究进一步补上机制细节:痰湿质与LDL受体基因Pvu II/Ava II多态性显著关联,且痰湿质人群甘油三酯、空腹血糖、餐后胰岛素均显著更高(PMID 17898945);高血压人群痰湿质血清脂联素显著更低,脂联素基因rs1063537的T等位基因携带者是其遗传特征(PMID 20681271);韩国卒中人群中NPY基因C-399T的T等位基因与痰湿证负相关(PMID 22110543)——同一”湿浊-代谢”关联在两个族裔中得到交叉印证。更宏观的证据来自双生子研究:四象体质遗传度估算高达47%-81%,共享环境效应几乎为零,说明体质很大程度上是”先天写好的蓝图”。

    二、为什么必须多中心重复验证

    上述证据真实但零散,存在三个结构性弱点:样本量小(几十到几百人,远低于现代GWAS的数万级门槛)、单中心单族裔(四象研究集中在韩国、九种体质研究集中在中国)、方法学不统一(不同量表、不同芯片、不同阈值)。这正是现代遗传学的”多中心GWAS+meta分析”要解决的问题——用统一表型定义(《中医体质分类与判定》量表)、统一质控流程,在多个独立中心采集大样本基因型,再跨群体合并统计量。2024年Yap与Morris的综述系统梳理了多族裔GWAS meta分析(MAGMA)的协议、统计方法与软件(PMID 39022911),指出跨族裔整合能提高检出功效并改善因果变异的精细定位;2026年Dias等人的大规模模拟与UK Biobank(约32.4万人)+All of Us(约20.7万人)实测表明,合并分析在控制群体分层后统计功效更优(PMID 40162269)。这些方法学成熟到可以直接套用——缺的不是工具,而是”九种体质”这个表型被拿去做大样本GWAS这件事本身。

    三、这条路走通意味着什么

    一旦九种体质在多个独立中心的大样本GWAS中复现出稳定位点,并跨族裔合并出体质多基因风险评分(PRS),体质学就能从”经验分类”升级为”可遗传表型指纹”:体质量表变成一张”表型PRS”,用症状和体征做代理,直接指向疾病易感性方向。这与4P医疗(个性化、预测、预防、参与)的框架完全同构——也是体质学真正融入精准医学的门票。反过来,如果多中心GWAS大面积复现失败,那将是对”体质可分”假说的最严厉证伪——这正是科学该有的样子。

    证据与局限

    已验证: 体质类型与特定基因多态性存在可重复关联(四象GWAS的SNP信号、痰湿质表达谱、LDL-R/APN/NPY/HLA多态性);痰湿质-代谢病易感在分子层面可解释;多族裔GWAS meta分析方法学成熟(PMID 39022911, 40162269)。

    部分验证: 九种体质中仅痰湿、阴虚、阳虚等少数类型有较充分遗传证据;现有GWAS多为韩国四象体质样本,中医九种体质尚无达到现代标准的大样本全基因组研究。

    待验证: ①统一体质量表下多中心大样本GWAS能否复现已知位点并发现新位点;②体质PRS能否独立预测疾病结局并跨族裔迁移;③体质-基因关联在不同环境暴露下是否稳定;④”体质可调”是否对应可测量的基因组/表观遗传变化。

    相关阅读

    证据等级: A
    参考文献: PMID 19954339, PMID 23548117, PMID 17898945, PMID 20681271, PMID 22110543, PMID 39022911, PMID 40162269


    免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

    Multi-center GWAS replication of the nine traditional Chinese medicine constitutions: from preliminary associations to reproducible phenotypic fingerprints

    Evidence level: A

    Multiple lines of genetic evidence support constitution classification, yet establishing “Nine Constitutions = Heritable Phenotypic Fingerprints” as a conclusion accepted by modern genetics requires completing the final validation link: multi-center large-sample GWAS combined with cross-population meta-analysis.

    Main Text

    Question: Can body mass scales identify whether you have the “Phlegm-Dampness Constitution” or the “Harmonious Constitution”? Does this classification hold up at the genomic level? The current answer is “there is preliminary evidence,” but it still lacks the final mile of “rigorous validation”—multi-center replication.

    I. Genetic Evidence for Constitution Classification Already Exists

    The genetic basis for constitution differences is not theoretical. In 2009, Kyung Hee University in Korea conducted the first genome-wide association study (GWAS) on four-constitution medicine, identifying 15,944 SNPs with significant differences between pairs of constitution types across 353,202 SNP loci, with 5 SNPs showing joint significance across all comparisons (PMID 19954339). Around the same time, Wang Qi’s team at Beijing University of Chinese Medicine performed gene expression profiling on the Phlegm-Dampness Constitution, identifying 4 upregulated genes (COPS8, GNPDA1, CD52, ARPC3) and 6 downregulated genes (GSPT2, CACNB2, etc.), pointing functionally toward susceptibility to hyperlipidemia and diabetes (PMID 23548117)—providing the first molecular anchor for the notion that “Phlegm-Dampness constitution predisposes to metabolic disorders.”

    Candidate gene studies further elucidate mechanistic details: the Phlegm-Dampness Constitution shows significant association with polymorphisms in the LDL receptor gene (Pvu II/Ava II), and individuals with this constitution exhibit significantly higher triglycerides, fasting glucose, and postprandial insulin (PMID 17898945); in hypertensive populations, serum adiponectin is significantly lower in the Phlegm-Dampness Constitution, with the T allele of adiponectin gene rs1063537 serving as a genetic characteristic (PMID 20681271); in Korean stroke populations, the T allele of the NPY gene C-399T shows a negative correlation with Phlegm-Dampness syndrome (PMID 22110543)—cross-validating the same “dampness-turbidity-metabolism” association across two ethnic groups. Broader evidence comes from twin studies: heritability estimates for four-constitution types range from 47% to 81%, with shared environmental effects nearly zero, indicating that constitution is largely a “pre-written blueprint.”

    II. Why Multi-Center Replication Is Necessary

    The above evidence is real but fragmented, exhibiting three structural weaknesses: small sample sizes (tens to hundreds of individuals, far below the tens-of-thousands threshold for modern GWAS), single-center/single-ethnicity (four-constitution studies concentrated in Korea, nine-constitution studies in China), and methodological heterogeneity (different scales, different chips, different thresholds). This is precisely what modern genetics addresses through “multi-center GWAS + meta-analysis”—using unified phenotypic definitions (e.g., the TCM Constitution Classification and Judgment scale), standardized quality control protocols, collecting large sample genotypes across independent centers, and then merging statistics across populations. A 2024 review by Yap and Morris systematically outlined protocols, statistical methods, and software for multi-ethnic GWAS meta-analysis (MAGMA) (PMID 39022911), noting that cross-ethnic integration improves detection power and refines causal variant localization; a 2026 large-scale simulation by Dias et al., alongside empirical data from UK Biobank (~324,000 individuals) and All of Us (~207,000 individuals), demonstrates that merged analysis yields superior statistical power after controlling for population stratification (PMID 40162269). These methodologies are mature enough for direct application—the missing component is not the tools, but whether the “Nine Constitutions” phenotype itself will be subjected to large-sample GWAS.

    III. What This Pathway Entails If Successful

    If the Nine Constitutions consistently replicate stable loci across multi-center large-sample GWAS and yield a constitution polygenic risk score (PRS) upon cross-ethnic merging, the field of constitution studies can evolve from “empirical classification” to “heritable phenotypic fingerprints”: the body mass scale becomes a “phenotype PRS,” using symptoms and signs as proxies to directly point toward disease susceptibility directions. This aligns perfectly with the 4P medical framework (personalized, predictive, preventive, participatory)—also serving as the ticket for constitution studies to truly integrate into precision medicine. Conversely, if multi-center GWAS fails to replicate broadly, it would constitute the most rigorous falsification of the “constitution categorization” hypothesis—exactly how science should operate.

    Evidence and Limitations

    Verified: Reproducible associations exist between constitution types and specific gene polymorphisms (SNP signals from four-constitution GWAS, expression profiles for Phlegm-Dampness, and polymorphisms in LDL-R/APN/NPY/HLA); the Phlegm-Dampness-metabolic disorder susceptibility is explainable at the molecular level; multi-ethnic GWAS meta-analysis methodologies are mature (PMID 39022911, 40162269).

    Partially Verified: Only a few constitution types within the Nine Constitutions (e.g., Phlegm-Dampness, Yin Deficiency, Yang Deficiency) have substantial genetic evidence; existing GWAS predominantly utilize Korean four-constitution samples, and no large-sample whole-genome study for TCM Nine Constitutions meets modern standards.

    Pending Verification: ① Can multi-center large-sample GWAS under a unified constitution scale replicate known loci and discover new ones? ② Can constitution PRS independently predict disease outcomes and transfer across ethnicities? ③ Are constitution-gene associations stable under different environmental exposures? ④ Does “modifiable constitution” correspond to measurable genomic or epigenetic changes.

    Related Reading

    Evidence Level: A
    References: PMID 19954339, PMID 23548117, PMID 17898945, PMID 20681271, PMID 22110543, PMID 39022911, PMID 40162269


    Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.